+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Results of a pilot study of very low dose craniospinal irradiation plus chemotherapy for children under five with medulloblastoma An update



Results of a pilot study of very low dose craniospinal irradiation plus chemotherapy for children under five with medulloblastoma An update



International Journal of Radiation Oncology Biology Physics 30(Suppl. 1): 170




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 033221831

Download citation: RISBibTeXText

DOI: 10.1016/0360-3016(94)90655-6


Related references

Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). International Journal of Radiation Oncology Biology Physics 34(4): 899-904, 1996

A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. International Journal of Radiation Oncology, Biology, Physics 60(2): 531-536, 2004

Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group. International Journal of Radiation Oncology*biology*physics 96(5): 937-938, 2016

Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study. Journal of BUON 18(2): 425-429, 2013

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet. Oncology 7(10): 813-820, 2006

A multi-institution prospective trial of reduced-dose craniospinal irradiation followed by conformal posterior fossa and primary site irradiation and dose-intensive chemotherapy for average-risk medulloblastoma. International Journal of Radiation Oncology Biology Physics 57(2 Suppl.): S194-S195, 2003

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. International Journal of Radiation Oncology Biology Physics 70(3): 782-787, 2008

Role of amifostine as a cytoprotectant in children ≥ 3 years with average risk (AR) medulloblastoma (MB) treated with craniospinal irradiation (CSI) and 4 courses of cisplatin (CDDP)-based high dose chemotherapy. Journal of Clinical Oncology 24(18_Suppl): 9063-9063, 2016

Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue. Pediatric Blood and Cancer 62(2): 317-321, 2015

Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. Journal of Clinical Oncology 12(6): 1212-1216, 1994

Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. Strahlentherapie und Onkologie 171(4): 247-248, 1995

Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors. Cancer 71(8): 2647-2652, 1993

Concurrent chemotherapy and low-dose craniospinal irradiation followed by conformal posterior fossa tumor bed boost for average risk medulloblastoma Efficacy and patterns of failure. International Journal of Radiation Oncology Biology Physics 54(2 Suppl.): 149, 2002

Feasibility and outcome of patients with medulloblastoma treated with pre-irradiation chemotherapy and reduced dose craniospinal radiotherapy (csrh) using mycc as a molecular marker for prognosis. Journal of Clinical Oncology 26(15_Suppl): 10040-10040, 2016

Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magnetic Resonance Imaging 18(7): 787-793, 2000